Are Themis Medicare latest results good or bad?
Themis Medicare's latest results are concerning, with a 33.6% decline in net sales to Rs 71.70 crore and significant losses in both Profit Before Tax and Profit After Tax, indicating ongoing operational challenges. Overall, the company's financial performance reflects considerable difficulties this quarter.
Themis Medicare has reported its financial results for the quarter ending March 2025, which indicate significant challenges in its operational and financial performance. The company recorded net sales of Rs 71.70 crore, which represents a notable decline of 33.6% compared to the average of the previous four quarters. This figure is the lowest sales recorded in the last five quarters, suggesting a concerning trend in sales performance.Profit Before Tax (PBT) for the quarter fell to Rs -12.68 crore, reflecting a substantial decline from the average PBT of the previous four quarters. Similarly, Profit After Tax (PAT) also dropped to Rs -9.66 crore, indicating a significant downturn in profitability. The operating profit margin has deteriorated to -8.08%, marking the lowest level in five quarters, which highlights ongoing challenges in operational efficiency.
The Earnings per Share (EPS) reached Rs -1.05, further emphasizing the declining profitability for shareholders. Additionally, the company experienced a quarterly decline in net sales and consolidated net profit compared to the previous quarter, with changes indicating a negative trend.
Overall, Themis Medicare's financial performance for this quarter reflects considerable difficulties, and the company has seen an adjustment in its evaluation based on these results.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
